OBN
Meet OBN at the UK Pavilion (Hall B, Stand 2348).
OBN’s core purpose is to catalyse success in UK life sciences, and as a not-for-profit member organisation everything we do is focused on helping our Members and the sector to thrive. Our membership of 460+ companies and organisations is spread across the UK with many in the Golden Triangle of Oxford, London and Cambridge. Members include pharma, biotech/medtechs, CXO’s, investors and associated industries (legal, IP, HR, PR etc). Becoming an OBN Member opens the door to a broad range of opportunities to catalyse your growth: via networking/partnering, our purchasing consortium, training and our consulting services. Our largest event is BioTrinity, an annual partnering and investment conference aimed at Series A companies, that attracts the best of life sciences in the UK. So if you are seeking connections in the UK life sciences sector, come and talk to us!
Your success is our success.
ONIX Life Sciences
Meet ONIX Life Sciences at the UK Pavilion (Hall B, Stand 2348).
ONIX Life Sciences was born twelve years ago in the UK, specializing in regulatory affairs, regulatory operations like CTIS uploads for clinical trials & eCTD publishing. In March 2023 ONIX was acquired by Framework Solutions LLC. Framework Solutions provides Clinical to Commercial Solutions to Biotechnology, and Pharmaceutical Companies with the goal of accelerating customer success. We provide both Strategic and Tactical Solutions in the areas of Medical Affairs, Regulatory, MLR, and Commercialization. These areas are supported by our Technology Group which offers tech-enabled solutions and integrated enterprise help desk/infrastructure support. We have provided services to over 225 clients ranging from Emerging Biotech to Large Pharma. We deliver these services globally with operation centers in North America, Europe, and Asia. For more information on our service offerings, visit our website at www.framesol.com / www.onixls.com and follow our page to stay up to date on the latest news! Transformation through Collaboration.
Oribiotech
Meet Oribiotech at the UK Pavilion (Hall B, Stand 2348).
Ori is a London and New Jersey based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and genetherapies. Ori has developed a proprietary, full stack manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics. Founded in 2015 by Dr. FarlanVeraitch (UCL), Ori has brought together a seasoned team with over 200 years of combined pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CDOO Kevin Gordon (Tmunity), CTO Stuart Milne (Cytiva), CCO Tom Heathman (Minaris), Chris Mason (AVROBIO), Paul Meister (Thermo Fisher) and Annalisa Jenkins (DimensionTx) alongside expert advisers like Bruce Levine and Robert Preti.
